Retrophin Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Retrophin (RTRX) PT Trimmed to $44 at Leerink Partners Post Q3, 'Outperform' Maintained
November 4, 2015 6:54 AM ESTLeerink Partners analyst Joseph Schwartz reiterated an Outperform rating but lowered his price target on Retrophin (NASDAQ: RTRX) to $44.00 (from $48.00) following Q3 results which beat on the top line. They note patient indemnification efforts are in focus.
Schwartz commented, "RTRX reported 3Q... More
